{
    "ticker": "ACHL",
    "name": "Achieve Life Sciences, Inc.",
    "description": "Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company dedicated to the development of smoking cessation and nicotine addiction treatment alternatives. Founded in 2018, Achieve Life Sciences is focused on addressing the global tobacco epidemic through innovative therapies. The company is primarily known for its lead product candidate, cytisine, a plant-derived alkaloid that has shown promise in aiding smoking cessation. Cytisine has been used for over 50 years in Eastern Europe and is being developed as a safer, effective alternative to traditional nicotine replacement therapies. Achieve Life Sciences aims to provide a comprehensive approach to nicotine addiction, offering solutions that can significantly improve quit rates among smokers. The company is committed to advancing public health and reducing the burden of tobacco-related diseases through rigorous clinical trials and research. Achieve is also exploring partnerships and collaborations to enhance its product development pipeline and expand access to its therapies globally.",
    "industry": [
        "Pharmaceuticals",
        "Biotechnology"
    ],
    "headquarters": "Vancouver, British Columbia, Canada",
    "founded": "2018",
    "website": "https://www.achievelifesciences.com",
    "ceo": "John Bencich",
    "social_media": {
        "twitter": "https://twitter.com/AchieveLifeSci",
        "linkedin": "https://www.linkedin.com/company/achieve-life-sciences"
    },
    "investor_relations": "https://www.achievelifesciences.com/investors",
    "key_executives": [
        {
            "name": "John Bencich",
            "position": "CEO"
        },
        {
            "name": "Michael Chaffin",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Smoking Cessation Products",
            "products": [
                "Cytisine"
            ]
        }
    ],
    "seo": {
        "meta_title": "Achieve Life Sciences, Inc. | Smoking Cessation Treatments",
        "meta_description": "Explore Achieve Life Sciences, Inc., a leader in smoking cessation therapies. Learn about cytisine, our commitment to public health, and innovative approaches to nicotine addiction.",
        "keywords": [
            "Achieve Life Sciences",
            "Cytisine",
            "Smoking Cessation",
            "Nicotine Addiction",
            "Pharmaceuticals"
        ]
    },
    "faq": [
        {
            "question": "What is Achieve Life Sciences known for?",
            "answer": "Achieve Life Sciences is known for its development of cytisine, a smoking cessation therapy."
        },
        {
            "question": "Who is the CEO of Achieve Life Sciences?",
            "answer": "John Bencich is the CEO of Achieve Life Sciences, Inc."
        },
        {
            "question": "Where is Achieve Life Sciences headquartered?",
            "answer": "Achieve Life Sciences is headquartered in Vancouver, British Columbia, Canada."
        },
        {
            "question": "What is cytisine?",
            "answer": "Cytisine is a plant-derived alkaloid used as a smoking cessation treatment with a long history of use in Eastern Europe."
        },
        {
            "question": "When was Achieve Life Sciences founded?",
            "answer": "Achieve Life Sciences was founded in 2018."
        }
    ],
    "competitors": [
        "CHRS",
        "MNMD",
        "VYNE"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "MRK",
        "ABBV"
    ]
}